PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: confidence

KDIGO 2012 Clinical Practice Guideline ... - KIDNEY DISEASE

Volume 3 | issue 1 | JANuARY 2013 JOurnal Of the internatiOnal SOciety Of nephrOlOgyKDIGO 2012 Clinical Practice Guideline for the Evaluation and management of Chronic KIDNEY DiseaseKDIGO 2012 Clinical Practice Guidelinefor the Evaluation and management ofChronic KIDNEY DiseaseKDIGO gratefully acknowledges the following consortium of sponsors that make our initiatives possible: Abbott, Amgen,Bayer Schering Pharma, Belo Foundation, Bristol-Myers Squibb, Chugai Pharmaceutical, Coca-Cola Company, Dole FoodCompany, Fresenius Medical Care, Genzyme, Hoffmann-LaRoche, JC Penney, Kyowa Hakko Kirin, NATCO TheOrganization for Transplant Professionals, NKF-Board of Directors, Novartis, Pharmacosmos, PUMC Pharmaceutical,Robert and Jane Cizik Foundation, Shire, Takeda Pharmaceutical, Transwestern Commercial Services, Vifor Pharma,and Statement.

100 Table 31. Peripheral arterial disease and CKD 103 Table 32. Cautionary notes for prescribing in people with CKD 107 Table 33. Risk factors for infection in people with CKD 110 Table 34. Components of community CKD management programs 114 Table 35. Early versus late referral: consequences and benefits 114 Table 36. Outcomes of early versus ...

Tags:

  Management, Disease

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of KDIGO 2012 Clinical Practice Guideline ... - KIDNEY DISEASE

Related search queries